Pre-order Enquiry
Request Free Sample
Global Drug Delivery Devices Sales Market Report 2023
SKU ID : QYR-23317555 | Publishing Date : 23-Mar-2023
Request Sample
Request Customization
Check Discounts
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
Market Analysis and Insights: Global Drug Delivery Devices Market
Due to the COVID-19 pandemic, the global Drug Delivery Devices market size is estimated to be worth US$ 41390 million in 2022 and is forecast to a readjusted size of US$ 58080 million by 2029 with a CAGR of 4.9% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Injection Type accounting for % of the Drug Delivery Devices global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Pharmaceutical Companies segment is altered to an % CAGR throughout this forecast period.
The top five global manufacturers of drug delivery equipment are Cipla, Baxter International, Nipro Corporation, Roche and Boehringer Ingelheim, with a combined market share of 29 per cent. North America, which has a well-established healthcare infrastructure and a large number of leading pharmaceutical and biopharmaceutical companies (around 80% of the world's research and development in biopharmaceutical is conducted by US-based firms), is the largest market for drug delivery, about for 47% followed by Europe with 28%.
Global Drug Delivery Devices Scope and Market Size
The global Drug Delivery Devices market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Drug Delivery Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2018-2029.
Segment by Type
Injection Type
Mucosal Type
Implanted Type
Others Type
Segment by Application
Pharmaceutical Companies
Hospitals
Clinics
Other
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Cipla
Baxter International
Nipro Corporation
Roche
Boehringer Ingelheim
Allergan
3M
BD
Catalent
Valeant Pharmaceuticals
Bayer AG
Chiesi
Phillips-Medisize
Johnson & Johnson
Shandong Weigao
Pfizer
B.Braun
Novartis AG
Zhengkang
Gerresheimer
COVIDIEN Medtronic
Schott forma vitrum
Alkermes
Skyepharma
Market Analysis and Insights: Global Drug Delivery Devices Market
Due to the COVID-19 pandemic, the global Drug Delivery Devices market size is estimated to be worth US$ 41390 million in 2022 and is forecast to a readjusted size of US$ 58080 million by 2029 with a CAGR of 4.9% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Injection Type accounting for % of the Drug Delivery Devices global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Pharmaceutical Companies segment is altered to an % CAGR throughout this forecast period.
The top five global manufacturers of drug delivery equipment are Cipla, Baxter International, Nipro Corporation, Roche and Boehringer Ingelheim, with a combined market share of 29 per cent. North America, which has a well-established healthcare infrastructure and a large number of leading pharmaceutical and biopharmaceutical companies (around 80% of the world's research and development in biopharmaceutical is conducted by US-based firms), is the largest market for drug delivery, about for 47% followed by Europe with 28%.
Global Drug Delivery Devices Scope and Market Size
The global Drug Delivery Devices market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Drug Delivery Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2018-2029.
Segment by Type
Injection Type
Mucosal Type
Implanted Type
Others Type
Segment by Application
Pharmaceutical Companies
Hospitals
Clinics
Other
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Cipla
Baxter International
Nipro Corporation
Roche
Boehringer Ingelheim
Allergan
3M
BD
Catalent
Valeant Pharmaceuticals
Bayer AG
Chiesi
Phillips-Medisize
Johnson & Johnson
Shandong Weigao
Pfizer
B.Braun
Novartis AG
Zhengkang
Gerresheimer
COVIDIEN Medtronic
Schott forma vitrum
Alkermes
Skyepharma
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
